Assessing symptoms of COVID-19 Kerra herbal medicines COVID-19 Molnupiravia
Conditions
Interventions
Take 8 tablets / day, 80 tablets divided into 2 tablets before breakfast, lunch, dinner and before bedtime for 10 days. Take the whole capsule. Explain to the experimental group so that they understan
Active Comparator Drug,Active Comparator Drug
Kerra ,Molnupiravia
Sponsors
EASTERN HERB COMPANY LIMITED
Eligibility
Sex/Gender
All
Age
18 Years to 59 Years
Inclusion criteria
Inclusion criteria: Being a confirmed case of COVID-19 asymptomatic or with mild symptoms, aged between 18-60 years, in good health no congenital disease Do not take any medication regularly. Normal body mass index (BMI) is 18-25 kg/m2. Do not smoke or drink alcohol regularly. and not addicted to drugs No history of drug allergies No complications, mental health problems, pregnancy, admitted during the project period, not having difficulty breathing. no pneumonia Able to communicate in Thai
Exclusion criteria
Exclusion criteria: Complications of mental health problems is in a condition that is not ready to provide information have significant comorbidities Female subjects became pregnant during drug administration. Subjects have characteristics that may cause inaccuracy of study results. The elimination is at the discretion of the physician.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| COVID-19 symptoms 30day questionaires,ATK 3 day ATK test,ATK 7day ATK test,ATK 10day ATK test | — |
Secondary
| Measure | Time frame |
|---|---|
| DASH score 4,6 weeks post operation DASH Questionaire | — |
Countries
Thailand
Contacts
Public ContactRungsan Butcha
prachomkao nursing college
Outcome results
None listed